Abdelazim, K. Et Al. 2024. The efficacy and safety of lecanemab 10 mg/kg biweekly compared to a placebo in patients with Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials. Neurological Sciences , vol.45, no.8 , 3583-3597.

Abdelazim, K., Allam, A. A., Afifi, B., Abdulazeem, H., & Elbehiry, A. I., (2024). The efficacy and safety of lecanemab 10 mg/kg biweekly compared to a placebo in patients with Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials. Neurological Sciences , vol.45, no.8, 3583-3597.

Abdelazim, Karim Et Al. "The efficacy and safety of lecanemab 10 mg/kg biweekly compared to a placebo in patients with Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials," Neurological Sciences , vol.45, no.8, 3583-3597, 2024

Abdelazim, Karim Et Al. "The efficacy and safety of lecanemab 10 mg/kg biweekly compared to a placebo in patients with Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials." Neurological Sciences , vol.45, no.8, pp.3583-3597, 2024

Abdelazim, K. Et Al. (2024) . "The efficacy and safety of lecanemab 10 mg/kg biweekly compared to a placebo in patients with Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials." Neurological Sciences , vol.45, no.8, pp.3583-3597.

@article{article, author={Karim Abdelazim Et Al. }, title={The efficacy and safety of lecanemab 10 mg/kg biweekly compared to a placebo in patients with Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials}, journal={Neurological Sciences}, year=2024, pages={3583-3597} }